Avaliação isocinética do torque muscular flexor-extensor do joelho em mulheres com idade entre 75-83 anos

OBJECTIVE: To assess knee flexor-extensor muscular strength in elderly women with no previous history of musculoskeletal disorders on the lower limbs using an isokinetic dynamometer, in order to obtain data that could be used as a comparative parameter in the evaluation of elderly women with knee disorders, thus facilitating a better rehabilitation of these patients. METHODS: Twenty-six volunteers aged 75 to 83 years were studied using a Cybex® 6000 isokinetic dynamometer. The chosen angular velocity was 60 º/s, and concentric exercise was used for either flexion or extension. The studied parameters were: peak torque, angle of peak torque, and flexor-extensor torque rate. RESULTS: There were no differences between dominant (D) and nondominant (ND) knee peak torque values. This was true for both flexor (D = 42.46 ± 9.09 Nm / ND = 40.65 ± 9.38 Nm) and extensor (D = 76.92 ± 13.97 Nm / ND = 77.65 ± 15.21 Nm) movements. The descriptive statistical analysis of the values obtained for the flexor-extensor peak torque rate and for the angle of occurrence of peak torque was the same for the dominant and nondominant sides. CONCLUSIONS: The values of peak torque for the contralateral side can be used as a reference during rehabilitation of elderly women with acute disease of the knee, and the angular velocity of 60 º/s is proper and safe for isokinetic assessment of elderly people.OBJETIVO: Avaliar, isocineticamente, o torque dos músculos flexores e extensores dos joelhos de mulheres idosas sem afecções do sistema músculo-esquelético em membros inferiores, obtendo dados que possam servir como parâmetro de comparação na avaliação de mulheres idosas portadoras de afecções nos joelhos, colaborando para uma melhor reabilitação dessas pacientes. CASUÍSTICA E MÉTODOS: Vinte e seis voluntárias foram avaliadas. O estudo foi realizado através de um dinamômetro isocinético marca CYBEX;â; modelo 6000 na velocidade angular de 60º/s. O tipo do exercício utilizado foi o concêntrico, tanto para a flexão quanto para a extensão do joelho. Os parâmetros avaliados foram o torque máximo, o ângulo de ocorrência do torque máximo e a relação flexão/extensão do torque máximo. RESULTADOS: Os resultados demonstraram não haver diferenças entre os valores do torque máximo do lado dominante (D) e do lado não dominante (ND). Isto foi verdadeiro tanto para o movimento flexor (D= 42,46 ± 9,09 Nm / ND= 40,65 ± 9,38 Nm), quanto para o movimento extensor (D= 76,92± 13,97 Nm / ND= 77,65 ± 15,21 Nm). Também, a estatística descritiva dos valores encontrados para a relação flexão/extensão do torque máximo e para o ângulo de ocorrência do torque máximo foram semelhantes nos dois lados avaliados. CONCLUSÕES: Os valores do torque máximo do lado contralateral podem ser usados como referência durante a reabilitação de mulheres idosas portadoras de doença articular aguda no joelho e a velocidade angular de 60º/s é adequada e segura para a avaliação isocinética em idosas

A preliminary overview of skin and skeletal diseases and traumata in small cetaceans from South American waters

We succinctly review and document new cases of diseases of the skin and the skeletal system and external traumata in cetaceans from Ecuador, Colombia, Peru, Chile, Argentina, Uruguay, Brazil, and Venezuela. The survey revealed 590 cases diagnosed with a significant pathology, injury or malformation on a total of 7635 specimens of 12 odontocete species examined or observed in 1984-2007. Tattoo skin disease (TSD), lobomycosis-like disease (LLD) and cutaneous diseases of unknown aetiology seem to be emerging in several populations. TSD was confirmed in eight species from the SE Pacific and SW Atlantic. LLD affected only inshore Tursiops truncatus but was found in four tropical countries, namely Colombia, Ecuador, Peru and Brazil. Lobomycosis was confirmed by histology in one male from the Tramandaí estuary, southern Brazil. All LLD-affected specimens were encountered in the vicinity of major ports and cities and a possible association with chemical or organic water pollution is suspected. Whitish velvety cutaneous marks associated with scars occurred in inshore T. truncatus, Sotalia guianensis and Pseudorca crassidens. Large, rounded lesions were seen in a Cephalorhynchus eutropia calf and a C. commersonii. Cutaneous wounds and scars as well as body traumata possibly related to net entanglements and boat collisions were observed in 73 delphinids and Phocoena spinipinnis. Traumatic injuries resulted in the partial or complete amputation and other disfiguring scars of appendages in 17 cases. Fractures of the skull, ribs and vertebrae thought to be caused by fisheries-related interactions or boat collisions were seen in single individuals of Delphinus capensis, Lagenorhynchus obscurus, T. truncatus, S. guianensis and Ziphius cavirostris. Prevalence of osteopathology in small cetaceans from Peru, Brazil and Venezuela ranged widely, from 5.4% to 69.1%. In four species from Peru, lytic cranial lesions were the most frequently observed disease (5.4%-42.9%), followed by hyperostosis and ankylosing spondylitis in offshore (31%, n=42) and inshore (15.4%, n=26) T. truncatus. Fractures and other bone traumata were present in 47.2% of 53 axial skeletons of S. guianensis from the northern Rio de Janeiro state (Brazil) in 1987-1998. A high prevalence (48.4%, n=31) of, apparently congenital, malformations of cervical vertebrae, observed in a 2001-2006 sample, may be explained by a hypothetical genetic bottleneck in this population. Malformations with deficient ossification would clearly increase susceptibility for fractures. This study demonstrates the utility of a continent-wide analysis to discern epizootiological trends more readily than any local study could provide. Secondly, it underscores the need for focussed research on the effects of human activities on the spread of diseases in cetaceans, particularly in near-shore populations that utilize highly degraded coastal habitats

HTLV-1 infection in solid organ transplant donors and recipients in Spain

HTLV-1 infection is a neglected disease, despite infecting 10-15 million people worldwide and severe illnesses develop in 10% of carriers lifelong. Acknowledging a greater risk for developing HTLV-1 associated illnesses due to immunosuppression, screening is being widely considered in the transplantation setting. Herein, we report the experience with universal HTLV testing of donors and recipients of solid organ transplants in a survey conducted in Spain. All hospitals belonging to the Spanish HTLV network were invited to participate in the study. Briefly, HTLV antibody screening was performed retrospectively in all specimens collected from solid organ donors and recipients attended since the year 2008. A total of 5751 individuals were tested for HTLV antibodies at 8 sites. Donors represented 2312 (42.2%), of whom 17 (0.3%) were living kidney donors. The remaining 3439 (59.8%) were recipients. Spaniards represented nearly 80%. Overall, 9 individuals (0.16%) were initially reactive for HTLV antibodies. Six were donors and 3 were recipients. Using confirmatory tests, HTLV-1 could be confirmed in only two donors, one Spaniard and another from Colombia. Both kidneys of the Spaniard were inadvertently transplanted. Subacute myelopathy developed within 1 year in one recipient. The second recipient seroconverted for HTLV-1 but the kidney had to be removed soon due to rejection. Immunosuppression was stopped and 3 years later the patient remains in dialysis but otherwise asymptomatic. The rate of HTLV-1 is low but not negligible in donors/recipients of solid organ transplants in Spain. Universal HTLV screening should be recommended in all donor and recipients of solid organ transplantation in Spain. Evidence is overwhelming for very high virus transmission and increased risk along with the rapid development of subacute myelopathy

Generation of the Brucella melitensis ORFeome version 1.1.

The bacteria of the Brucella genus are responsible for a worldwide zoonosis called brucellosis. They belong to the alpha-proteobacteria group, as many other bacteria that live in close association with a eukaryotic host. Importantly, the Brucellae are mainly intracellular pathogens, and the molecular mechanisms of their virulence are still poorly understood. Using the complete genome sequence of Brucella melitensis, we generated a database of protein-coding open reading frames (ORFs) and constructed an ORFeome library of 3091 Gateway Entry clones, each containing a defined ORF. This first version of the Brucella ORFeome (v1.1) provides the coding sequences in a user-friendly format amenable to high-throughput functional genomic and proteomic experiments, as the ORFs are conveniently transferable from the Entry clones to various Expression vectors by recombinational cloning. The cloning of the Brucella ORFeome v1.1 should help to provide a better understanding of the molecular mechanisms of virulence, including the identification of bacterial protein-protein interactions, but also interactions between bacterial effectors and their host's targets

Risk profiles and one-year outcomes of patients with newly diagnosed atrial fibrillation in India: Insights from the GARFIELD-AF Registry.

BACKGROUND: The Global Anticoagulant Registry in the FIELD-Atrial Fibrillation (GARFIELD-AF) is an ongoing prospective noninterventional registry, which is providing important information on the baseline characteristics, treatment patterns, and 1-year outcomes in patients with newly diagnosed non-valvular atrial fibrillation (NVAF). This report describes data from Indian patients recruited in this registry. METHODS AND RESULTS: A total of 52,014 patients with newly diagnosed AF were enrolled globally; of these, 1388 patients were recruited from 26 sites within India (2012-2016). In India, the mean age was 65.8 years at diagnosis of NVAF. Hypertension was the most prevalent risk factor for AF, present in 68.5% of patients from India and in 76.3% of patients globally (P < 0.001). Diabetes and coronary artery disease (CAD) were prevalent in 36.2% and 28.1% of patients as compared with global prevalence of 22.2% and 21.6%, respectively (P < 0.001 for both). Antiplatelet therapy was the most common antithrombotic treatment in India. With increasing stroke risk, however, patients were more likely to receive oral anticoagulant therapy [mainly vitamin K antagonist (VKA)], but average international normalized ratio (INR) was lower among Indian patients [median INR value 1.6 (interquartile range {IQR}: 1.3-2.3) versus 2.3 (IQR 1.8-2.8) (P < 0.001)]. Compared with other countries, patients from India had markedly higher rates of all-cause mortality [7.68 per 100 person-years (95% confidence interval 6.32-9.35) vs 4.34 (4.16-4.53), P < 0.0001], while rates of stroke/systemic embolism and major bleeding were lower after 1 year of follow-up. CONCLUSION: Compared to previously published registries from India, the GARFIELD-AF registry describes clinical profiles and outcomes in Indian patients with AF of a different etiology. The registry data show that compared to the rest of the world, Indian AF patients are younger in age and have more diabetes and CAD. Patients with a higher stroke risk are more likely to receive anticoagulation therapy with VKA but are underdosed compared with the global average in the GARFIELD-AF. CLINICAL TRIAL REGISTRATION-URL: http://www.clinicaltrials.gov. Unique identifier: NCT01090362